X4 Pharmaceuticals, Inc. Q4 Loss Climbs

X4 Pharmaceuticals, Inc. (XFOR) revealed Loss for its fourth quarter of -$39.82 million

The company's earnings totaled -$39.82 million, or -$0.20 per share. This compares with -$19.13 million, or -$0.10 per share, last year.

X4 Pharmaceuticals, Inc. earnings at a glance (GAAP) :

-Earnings: -$39.82 Mln. vs. -$19.13 Mln. last year.
-EPS: -$0.20 vs. -$0.10 last year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com